TOS-BB-0910

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

205 API Suppliers, 53 USDMF, 35 CEP/COS, 9 JDMF, 41 EU WC, 61 KDMF, 32 NDC API, 112 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

53 Intermediate Suppliers

53 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1454 FDF Dossiers, 339 FDA Orange Book, 666 Europe, 114 Canada, 43 Australia, 62 South Africa, 230 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 165MG, TABLET, EXTENDED RELEASE;ORAL - 330MG, TABLET, EXTENDED RELEASE;ORAL - 82.5MG, CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 150MG, CAPSULE;ORAL - 200MG, CAPSULE;ORAL - 225MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 300MG, CAPSULE;ORAL - 50MG, CAPSULE;ORAL - 75MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 3 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Bioplus Life Sciences, 2 DFE Pharma, 1 Finar, 3 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 15 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 4 Pluviaendo, 1 Qualicaps, 8 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders, 10 Coating Systems & Additives, 10 Direct Compression, 8 Taste Masking, 8 Empty Capsules, 8 Granulation, 7 Thickeners and Stabilizers, 6 Lubricants & Glidants, 5 Co-Processed Excipients, 5 Film Formers & Plasticizers, 4 Topical, 3 Disintegrants & Superdisintegrants, 3 Coloring Agents, 3 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 3 Emulsifying Agents, 2 Parenteral, 2 Solubilizers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents